Sage Journals: Discover world-class research

Abstract

Background

There is limited evidence on the epidemiology and prognostic significance of acid-base disorders in the cardiovascular intensive care unit (CICU). This study examines the association of acid-base status at admission with in-hospital mortality among CICU patients.

Methods

We conducted a retrospective analysis of adults admitted to the Mayo Clinic CICU from 2007-2018 with available blood gas data, utilizing values obtained closest to CICU admission. Arterial pH, serum bicarbonate, base excess, and partial pressure of carbon dioxide (PaCO₂) were examined as predictors of in-hospital mortality. Multivariable logistic regression was used to assess associations, with adjustment for demographics, comorbidities, illness severity, and interventions.

Results

Among 3229 patients included for analysis, acidemia (pH < 7.35) emerged as the strongest predictor of in-hospital mortality (adjusted odds ratio [aOR] 1.60, 95% confidence interval [CI] 1.29-1.98, P < .003). Metabolic acidosis (HCO3 < 20 mEq/L, aOR 1.55, 95% CI 1.24-1.95, P < .001) and respiratory acidosis (PaCO2 > 45 mm Hg, aOR 1.44, 95% CI 1.14-1.81, P = .002) were associated with higher in-hospital mortality, whereas metabolic and respiratory alkalosis were not. After adjustment, lower pH and more negative base excess were associated with higher in-hospital mortality (both P < .001), whereas HCO3 and PaCO2 were not (P = .053 and P = .051, respectively). Patients with combined metabolic and respiratory acidosis had the highest in-hospital mortality (56.3%).

Conclusions

Short-term survival in CICU patients decreases progressively with worse acidemia, especially in the context of combined metabolic and respiratory acidosis. Incorporating metabolic acid-base disorders as key therapeutic targets in randomized cardiogenic shock trials may improve outcomes in this complex population by addressing hemometabolic shock.

Keywords

metabolic acidosis respiratory acidosis acid-base disturbances cardiac intensive care unit hemometabolic shock

Get full access to this article

View all access options for this article.

References

Jentzer

Schrage

Patel

, et al. Association between the acidemia, lactic acidosis, and shock severity with outcomes in patients with cardiogenic shock. J Am Heart Assoc. 2022;11(9):e024932.

Jentzer

Kashani

Wiley

, et al. Laboratory markers of acidosis and mortality in cardiogenic shock: Developing a definition of hemometabolic shock. Shock. 2022;57(1):31‐40.

Jung

Rimmele

Le Goff

, et al. Severe metabolic or mixed acidemia on intensive care unit admission: Incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care. 2011;15(5):R238.

Mochizuki

Fujii

Paul

, et al. Acidemia subtypes in critically ill patients: An international cohort study. J Crit Care. 2021;64:10‐17. doi:10.1016/j.jcrc.2021.02.006

Burstein

Vallabhajosyula

Ternus

Barsness

Kashani

Jentzer

. The prognostic value of lactate in cardiac intensive care unit patients with cardiac arrest and shock. Shock. 2021;55(5):613‐619.

Jentzer

van Diepen

Barsness

, et al. Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population. Am Heart J. 2019;215:12‐19. doi:10.1016/j.ahj.2019.05.012

Jentzer

Sanghavi

Patel

, et al. Prognostic performance of serial determination of the society for cardiovascular angiography and interventions shock classification in adults with critical illness. Shock. 2024;61(2):246‐252.

Breen

Padkins

Bennett

, et al. Predicting 1-year mortality on admission using the mayo cardiac intensive care unit admission risk score. Mayo Clin Proc. 2021;96(9):2354‐2365.

Jentzer

Anavekar

Bennett

, et al. Derivation and validation of a novel cardiac intensive care unit admission risk score for mortality. J Am Heart Assoc. 2019;8(17):e013675.

10.

Jentzer

Bennett

Wiley

, et al. Predictive value of the sequential organ failure assessment score for mortality in a contemporary cardiac intensive care unit population. J Am Heart Assoc. 2018;7(6):e008169.

11.

Bennett

Wright

Jentzer

, et al. Severity of illness assessment with application of the APACHE IV predicted mortality and outcome trends analysis in an academic cardiac intensive care unit. J Crit Care. 2019;50:242‐246. doi:10.1016/j.jcrc.2018.12.012

12.

Patel

Jentzer

Alviar

, et al. A pragmatic lab-based tool for risk assessment in cardiac critical care: Data from the critical care cardiology trials network (CCCTN) registry. Eur Heart J Acute Cardiovasc Care. 2022;11(3):252‐257.

13.

Jentzer

van Diepen

Murphree

, et al. Admission diagnosis and mortality risk prediction in a contemporary cardiac intensive care unit population. Am Heart J. 2020;224:57‐64. doi:10.1016/j.ahj.2020.02.018

14.

Olsen

Nedergaard

Strøm

, et al. Nonsedation or light sedation in critically ill, mechanically ventilated patients. N Engl J Med. 2020;382(12):1103‐1111.

15.

Ingraham

Vakayil

Pendleton

, et al. Recent trends in admission diagnosis and related mortality in the medically critically ill. J Intensive Care Med. 2022;37(2):185‐194.

16.

Bohula

Katz

van Diepen

, et al. Demographics, care patterns, and outcomes of patients admitted to cardiac intensive care units: The critical care cardiology trials network prospective north American multicenter registry of cardiac critical illness. JAMA Cardiol. 2019;4(9):928‐935.

17.

Miller

Thomas

Breen

, et al. Prevalence of noncardiac multimorbidity in patients admitted to two cardiac intensive care units and their association with mortality. Am J Med. 2021;134(5):653‐61.e5.

18.

Attanà

Lazzeri

Chiostri

Picariello

Gensini

Valente

. Strong-ion gap approach in patients with cardiogenic shock following ST-elevation myocardial infarction. Acute Card Care. 2013;15(3):58‐62.

19.

Zante

Reichenspurner

Kubik

Kluge

Schefold

Pfortmueller

. Base excess is superior to lactate-levels in prediction of ICU mortality after cardiac surgery. PLoS One. 2018;13(10):e0205309.

20.

Davis

Dirks

Kaups

Tran

. Base deficit is superior to lactate in trauma. Am J Surg. 2018;215(4):682‐685.

21.

Kimmoun

Novy

Auchet

Ducrocq

Levy

. Hemodynamic consequences of severe lactic acidosis in shock states: From bench to bedside. Crit Care. 2015;19(1):175.

22.

Ghauri

Javaeed

Mustafa

Podlasek

Khan

. Bicarbonate therapy for critically ill patients with metabolic acidosis: A systematic review. Cureus. 2019;11(3):e4297.

23.

Baran

Grines

Bailey

, et al. SCAI Clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the society of critical care medicine (SCCM), and the society of thoracic surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019;94(1):29‐37.

24.

Vidal

Grassin-Delyle

Devillier

, et al. Effect of severe acidosis on vasoactive effects of epinephrine and norepinephrine in human distal mammary artery. J Thorac Cardiovasc Surg. 2014;147(5):1698‐1705.

25.

Jentzer

Tabi

Burstein

. Managing the first 120 min of cardiogenic shock: From resuscitation to diagnosis. Curr Opin Crit Care. 2021;27(4):416‐425.

26.

Zweck

Thayer

Helgestad

OKL

, et al. Phenotyping cardiogenic shock. J Am Heart Assoc. 2021;10(14):e020085.

27.

Evans

Rhodes

Alhazzani

, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181‐1247.

28.

Cooper

Walley

Wiggs

Russell

. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med. 1990;112(7):492‐498.

29.

Mathieu

Neviere

Billard

Fleyfel

Wattel

. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: A prospective, controlled clinical study. Crit Care Med. 1991;19(11):1352‐1356.

30.

Jaber

Paugam

Futier

, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): A multicentre, open-label, randomised controlled, phase 3 trial. Lancet. 2018;392(10141):31‐40.

31.

van Diepen

Tymchak

Bohula

, et al. Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the critical care cardiology trials network registry. Am Heart J. 2020;222:8‐14. doi:10.1016/j.ahj.2020.01.005

32.

Liu

Mao

Zhou

. Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: A systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. Crit Care. 2021;25(1):15.

33.

Radosevich

Wieruszewski

Wittwer

. Tris-Hydroxymethyl aminomethane in critically ill adults: A systematic review. Anesth Analg. 2023;137(5):1007‐1018.

34.

Jentzer

van Diepen

Barsness

, et al. Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol. 2019;74(17):2117‐2128.

35.

Yadav

Harrison

Hanson

Gajic

Kor

Cartin-Ceba

. Improving the accuracy of cardiovascular component of the sequential organ failure assessment score. Crit Care Med. 2015;43(7):1449‐1457.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.66 MB

Admission Acid-Base Status and Mortality in Cardiac Intensive Care Unit Patients

Abstract

Background

Methods

Results

Conclusions

Keywords

Get full access to this article

References

Supplementary Material